Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-ALA HCl for Photodynamic Diagnosis of Malignant Glioma
NCT06160492Phase 3Recruiting
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Apr 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of 5-aminolevulinic acid in glioma, sponsored by Lee's Pharmaceutical Holdings Limited. Started Apr 2025; status: recruiting.
02
Drugs
5-aminolevulinic acid
03
Conditions
glioma
Beyond the preview
Go deeper on NCT06160492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06160492.